Global market demand for technologies driving better balance between procedural value and volumes of incisionless surgeries
The shift towards value-based care have forced hospitals to adopt minimally invasive surgical procedures, which offers better clinical outcomes in the form of lesser operating time, reduced post-surgical complications, faster recovery speeds, low bleeding rates during performance of the procedure, and reduction in the overall costs of such procedures. Incisionless surgeries are proving to the gold standard for accomplishing a range of diagnostic and therapeutic procedures for managing chronic and severe conditions not limited to cancer.
Increasing emphasis on value-based care has imposed pressure on hospitals to source technologies that can help retain existing procedural volumes while maximizing the clinical outcomes and costs associated with such incisionless procedures. This research service focuses on various technologies that enable hospitals to maximize the value of incisionless surgeries prescribed to patients (especially old age and critical cases), while achieving an optimal balance on the volume of procedures performed within the same premises.
The first section focuses on the current industry snapshot and segmentation of the global incisionless surgeries market. The section outlines the supplier landscape, major end-user segments and products that cater to various clinical applications. The section also brings out the critical growth factors that differentiate competitive performance and outlines the key R&PD initiatives that are necessary to achieve optimal balance between procedural volumes and value.
The second section focuses on the critical technology success factors that are necessary for hospitals to improve the value of incisionless surgeries, while optimizing their procedural volumes critical to meet revenue and business performance. The section also uncovers technology factors that are critical to retaining or enhancing procedural volumes, focusing on improved turnaround time, efficient OR use and reduced costs of laparopscopic procedures such as use of handheld microsurgical instruments.
The third section focuses on the prioritization of technology factors that contribute to procedural volumes and value, which demonstrate an optimal balance between supply of such technologies to meet the existing demand. The section also uncovers the critical business models that enable hospitals achieve their targets fixed for procedural value and volumes for various customer segments and regions.